{"title":"部分阻塞的冠状动脉合并血小板血栓:环氧化酶抑制剂与前列环素预防的比较。","authors":"J W Aiken, R J Shebuski, R R Gorman","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>This study shows that in vivo, platelet aggregation occurs by both cyclooxygenase- and noncyclooxygenase-dependent mechanisms, so that blockage of partially obstructed coronary arteries still occurs after cyclooxygenase inhibition if the obstruction is severe enough. Prostacyclin prevents blockage of the vessels under all conditions. Furthermore, prostacyclin's ability to block primary aggregation is enhanced after cyclooxygenase inhibition.</p>","PeriodicalId":75450,"journal":{"name":"Advances in prostaglandin and thromboxane research","volume":"7 ","pages":"635-9"},"PeriodicalIF":0.0000,"publicationDate":"1980-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Blockage of partially obstructed coronary arteries with platelet thrombi: comparison between its prevention with cyclooxygenase inhibitors versus prostacyclin.\",\"authors\":\"J W Aiken, R J Shebuski, R R Gorman\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This study shows that in vivo, platelet aggregation occurs by both cyclooxygenase- and noncyclooxygenase-dependent mechanisms, so that blockage of partially obstructed coronary arteries still occurs after cyclooxygenase inhibition if the obstruction is severe enough. Prostacyclin prevents blockage of the vessels under all conditions. Furthermore, prostacyclin's ability to block primary aggregation is enhanced after cyclooxygenase inhibition.</p>\",\"PeriodicalId\":75450,\"journal\":{\"name\":\"Advances in prostaglandin and thromboxane research\",\"volume\":\"7 \",\"pages\":\"635-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1980-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in prostaglandin and thromboxane research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in prostaglandin and thromboxane research","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Blockage of partially obstructed coronary arteries with platelet thrombi: comparison between its prevention with cyclooxygenase inhibitors versus prostacyclin.
This study shows that in vivo, platelet aggregation occurs by both cyclooxygenase- and noncyclooxygenase-dependent mechanisms, so that blockage of partially obstructed coronary arteries still occurs after cyclooxygenase inhibition if the obstruction is severe enough. Prostacyclin prevents blockage of the vessels under all conditions. Furthermore, prostacyclin's ability to block primary aggregation is enhanced after cyclooxygenase inhibition.